Alnylam Pharmaceuticals
ALNY
ALNY
198 hedge funds and large institutions have $4.22B invested in Alnylam Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
6% less funds holding
Funds holding: 210 → 198 (-12)
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
Holders
198
Holding in Top 10
8
Calls
$45.9M
Puts
$43.4M
Top Buyers
| 1 | +$243M | |
| 2 | +$50.5M | |
| 3 | +$25.4M | |
| 4 |
Goldman Sachs
New York
|
+$24.1M |
| 5 |
RI
RTW Investments
New York
|
+$15.5M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$11.2M | |
| 3 | -$10.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$10M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$8.14M |